RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 62 - per page Next page
Order by
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More
This technology overcomes the amount of time required to culture and identify pathogens, using standard collection methods, is able to identify over 98% of relevant pathogens, and is a fully automated process More
A DNA microarray that becomes a protein microarray on demand and provides an efficient systematic approach to the study of protein interactions and drug target identification and validation. More
A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More
Biomarker and possible therapeutic target for a variety of neurodegenerative diseases More
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
Universal and type-specific assays for detection of C. botulinum More
Two novel classes of compounds useful as radioligands for in vivo imaging of beta-amyloid peptides and plaques in humans More
Displaying 1..10 of 62 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us